H36.821
Proliferative sickle-cell retinopathy, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Proliferative sickle-cell retinopathy is a complication of sickle cell disease that affects the retina, the light-sensitive layer at the back of the eye. When it describes the right eye specifically, it indicates that the disease process is present in this eye. This condition involves abnormal blood vessel growth due to damage caused by sickled red blood cells, which can lead to serious vision problems if left untreated. Recognizing and understanding this eye condition is vital for patients with sickle cell disease to seek early intervention and preserve their eyesight.
Causes & Symptoms
Clinical Causes: Sickle-shaped red blood cells that stick together and block blood flow in tiny blood vessels of the retina Chronic damage to retinal blood vessels from repeated sickling episodes Low oxygen levels in the blood stimulating abnormal vessel growth
Key Symptoms: Sudden or gradual loss of vision Floaters or dark spots in the visual field Blurred vision or visual distortions Patchy areas of vision loss
Diagnostic & Treatment
Diagnosis Path: Dilated fundus examination to observe abnormal blood vessel growth Fluorescein angiography to visualize blood flow in retinal vessels Optical coherence tomography (OCT) to assess retinal structure Medical history review to confirm sickle cell disease diagnosis
Treatment Protocols: Laser therapy (photocoagulation) to obliterate abnormal blood vessels and prevent bleeding Vitrectomy in cases of significant bleeding or scar tissue formation Treating sickle cell disease to reduce episodes of sickling and protect ocular health Regular monitoring by an ophthalmologist for early detection of progression
Clinical Advice & FAQs
Billing Guidance
Is H36.821 a billable ICD-10 code?
Yes, H36.821 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H36.821?
Clinical documentation must specify the nature of Proliferative sickle-cell retinopathy, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference